Why Copying a Billionaire's Stock Picks Doesn't Work
I did it once — saw a headline that a well-known value investor had built a large new position in a stock, and I bought in that same afternoon, no further research. Let me give you the conclusion first, because it’s more useful than the story: the information you’re acting on is already weeks old, it’s missing more than half the picture, and there’s no reliable evidence the investor you’re copying will even be a top performer again next year. Copying isn’t a shortcut to their edge. It’s a different trade wearing the same ticker.
This is a different failure mode than the one covered in why crowds behave irrationally during a crash — that piece is about panic and herd psychology under stress. This one is about something narrower and, in a way, more mechanical: what actually breaks when you try to structurally copy someone else’s trade, calm market or not.
What “Copying” Actually Means
There are two versions of this behavior, and they share the same psychological engine. The first is literal: mirror-trading apps and platforms that let you auto-replicate another trader’s buys and sells in your own account, often in near real time. The second is looser but far more common — reading that a famous investor or a large fund bought a stock, and buying it yourself off the back of that headline, with no app involved at all.
Both are driven by the same instinct: trust transfer. You’re not doing the analysis — you’re borrowing someone else’s presumed analysis and treating their action as if it were a verified signal instead of a data point with a huge asterisk attached. It feels efficient. It feels like free research. The problem is what’s baked into that transfer, which the next two sections unpack.
The Filing Is Always Old News
In many markets, securities regulators require large institutional investors to disclose their equity holdings — but only periodically, and only after a lag. A common pattern: a disclosure filed in mid-May might reflect a snapshot of what the fund held as of March 31. That’s a lag of up to roughly 45 days, about six weeks, between the actual position and the moment you can see it.
Six weeks doesn’t sound catastrophic until you think about what can happen inside it. A fund with meaningfully high turnover can build, trim, or fully exit a position in that window — and by the time the filing becomes public, the trade you’re “copying” may already be finished from their side. You’re not trading alongside them. You’re trading a snapshot of a decision that’s already aging, in a market that reacts to information near-instantly — the same speed gap that shows up in why you can’t out-run high-frequency algorithms, just stretched from milliseconds to weeks. The more actively a fund trades, the faster any real edge decays by the time you can act on it.
What a Disclosure Never Shows You
Here’s the part that’s easy to skip past: a holdings disclosure tells you what was bought. It tells you almost nothing about why, or what happens next.
It typically won’t show you:
- What percentage of the fund’s total portfolio that position represents
- Whether the position is hedged with options or offsetting trades elsewhere
- How long they intend to hold it
- Whether the purchase was a small starter position or a fully built conviction bet
- Any tax-driven sale, client redemption, index rebalancing, or risk-management trim that later triggered an exit
There’s a blunt way to put this: you get to see the buy. You basically never get to see the sell coming. By the time a disclosure confirms they’ve reduced or exited, it’s already the same 45-day-old news all over again — you’re perpetually one filing cycle behind their decision-making, both in and out.
Why Last Year’s Winner Rarely Repeats
Even setting the disclosure-lag problem aside, there’s a deeper issue: assuming last year’s best performer stays this year’s best performer.
S&P Dow Jones Indices’ U.S. Persistence Scorecard — measured specifically on U.S. large-cap active mutual funds, not on retail copy traders — tracks how often top-ranked funds stay on top. The results are stark. Of large-cap funds that ranked in the top quartile in December 2020, 0% stayed in the top quartile in each of the four following years (through December 2024). Funds that started in the top half fared only slightly better: roughly 2.42% kept a top-half ranking across the same four years. Looking at a shorter, two-year window (December 2022 to December 2024), the pattern repeats: none of the top-quartile large-cap funds held onto that ranking either — 0%, versus an expected 6.25% under pure random chance — while only 9% of above-median large-cap funds stayed above median, versus the roughly 25% you’d expect at random.
This lines up with Eugene Fama and Kenneth French’s widely cited 2010 Journal of Finance research on mutual fund performance: after costs, the great majority of active managers’ apparent alpha is statistically indistinguishable from luck. None of this is a claim that any specific investor lacks skill — it’s a claim about base rates. Betting your own money on “this year’s winner repeats” is closer to betting on a streak than on a skill you can independently verify. This is also a distinct question from whether active funds beat index funds overall — that’s about average returns net of fees; this is specifically about whether rank persists, which matters more if your whole strategy is “find the current leader and copy them.”
The Sizing Mismatch Nobody Talks About
Even if you got the timing and the stock exactly right, there’s a structural problem baked into copying by nature: your portfolio and theirs are not the same size, and the position almost certainly isn’t the same percentage of either one.
A billionaire investor or large fund might build a position that’s 1% of their total net worth or fund — a meaningful bet for them, but one loss they could absorb without much trouble. If you put 20% of your own portfolio into the same stock because “they bought it,” you’re not replicating their trade. You’re replicating their ticker while running a completely different risk profile.
Position-sizing mismatch: same stock, very different risk (assumption: the stock later falls 50%; reference position = 1% of portfolio, roughly what a highly diversified large fund might hold in a single name)
| Your position size | Portfolio-level loss if the stock falls 50% | Risk multiple vs. a 1% position |
|---|---|---|
| 1% | 0.5% | 1x |
| 5% | 2.5% | 5x |
| 10% | 5.0% | 10x |
| 20% | 10.0% | 20x |
| 33% | 16.5% | 33x |
| 50% | 25.0% | 50x |
The math is simple multiplication (position size × drawdown), but the takeaway isn’t: a 20% position doesn’t carry “somewhat more” risk than a 1% position — it carries 20 times more portfolio-level exposure to the exact same stock price move. To make it concrete: on a $50,000 portfolio, a 20% position ($10,000) that falls 50% costs you $5,000 — 10% of everything you have — from a single stock, off the back of one headline.
This connects directly to two more foundational questions worth answering before you copy anyone: how much risk you can actually tolerate, and what your overall asset allocation should look like. Neither of those questions has anything to do with what a famous investor bought — they’re about you.
Herding, FOMO, and the Efficiency Problem
There’s also a behavioral layer sitting underneath all of this. Academic research on copy-trading platforms specifically (Apesteguia, Oechssler, and Weidenholzer, published in Management Science in 2020) found that the mechanics of copying itself — not just the information gap — measurably increases the risk appetite of the people doing the copying. Watching someone else’s return and mirroring it seems to loosen the usual caution people apply to their own money. Separately, IOSCO, the International Organization of Securities Commissions, flagged in its 2024–2025 work on social and copy trading that copy traders tend to over-rely on a trader’s past performance record and are exposed to survivorship bias — the highest-performing accounts that get featured and followed are, almost by definition, the ones that haven’t yet had a bad year.
On the crowding question specifically, it’s worth being precise rather than dramatic: it isn’t automatically true that “everyone piling into the same trade” guarantees a loss. The more defensible version of the argument is about price efficiency — by the time a position is public, widely reported, and heavily followed, a meaningful part of any expected gain may already be reflected in the price, simply because so much capital and attention arrived at once. That’s a reason for caution, not a guarantee of failure.
Key Takeaways
Copying a well-known investor’s trade isn’t research — it’s outsourcing your due diligence to a source with a built-in weeks-long delay and none of the context you’d actually need.
- Confirm the disclosure lag before acting — a filing you’re seeing today may reflect a position from six weeks ago or more.
- Remember you’re seeing the buy, not the sell — exits show up on the same delay, if at all, before it’s public.
- Don’t assume last year’s top performer repeats — SPIVA persistence data (U.S. large-cap active funds) shows top-quartile four-year persistence near 0%.
- Check your position size against theirs — a 1% stake for them can be a 20x-larger risk for you at 20%.
- Ask whether the move is already priced in — heavily followed trades may have less room left to run by the time you can act.
- Treat their disclosed holdings as a research starting point, not a signal — avoiding the temptation to time the entry and instead building the position gradually beats reacting to a single headline.
Frequently Asked Questions
Why are large institutional stock holdings disclosed with a delay, and how long is the lag? In many markets, regulators require large institutional investors to periodically disclose their equity holdings, but only after quarter-end, with a lag that can run up to roughly 45 days (about six weeks). A filing made public in mid-May, for example, can reflect a snapshot of holdings as of March 31 — meaning what you’re seeing is already dated by the time you can act on it.
If I buy the same stock as a famous hedge fund, will I get the same return? Not necessarily, and often not closely. You’re buying at a different price weeks after their entry, you don’t know their exit plan, and your position is almost certainly a very different percentage of your total portfolio than theirs is of their fund. Same ticker, different trade.
Does a fund that ranked at the top in the past tend to stay at the top? Rarely, based on the available evidence. SPIVA’s Persistence Scorecard, measured on U.S. large-cap active mutual funds, found 0% of top-quartile funds stayed top-quartile for four consecutive years, and only about 2.42% of top-half funds held a top-half ranking that long. This is a statement about fund rankings specifically, not a claim about individual copy traders.
What information does a holdings disclosure never show you? It shows what was bought, not the full picture: what percentage of the total portfolio the position represents, whether it’s hedged, how long the holder plans to keep it, or whether a later reduction was tax-driven, a client redemption, a rebalancing, or a genuine change of view. You see the buy; the sell is invisible until the next delayed filing, if it’s visible at all.
If I buy the same stock as a billionaire, will I get the same result? Only if your position size relative to your portfolio matches theirs relative to their net worth — and it usually doesn’t. A stake that’s 1% of a billionaire’s net worth might be 20% of your account if you go all-in on the headline, which means the same 50% stock decline costs you 20 times more of your total wealth than it costs them.
What is herding, and why can it hurt copy trading? Herding is when a large number of investors buy or sell the same asset around the same time, often triggered by the same news or the same followed trader. It isn’t automatically true that herding guarantees a loss, but by the time a trade is public and heavily followed, a meaningful part of its expected gain may already be reflected in the price — leaving less room to run for investors arriving late.
I still check what well-known investors are buying sometimes — old habits. But now I treat it as one research lead among many, not a trade ticket, and I check my own position size against my own risk tolerance before I touch a single share.